Ovarian cancer

Open Access
Hyperthermic Intraperitoneal Chemotherapy in the Management of Primary Epithelial Ovarian Cancer: A Debated Issue for Gynecologic Oncologists
ANGIOLO GADDUCCI, STEFANIA COSIO and PIERO VINCENZO LIPPOLIS

Anticancer Research October 2022, 42 (10) 4659-4665; DOI: https://doi.org/10.21873/anticanres.15970
You have access
Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer
JUHUN LEE and DAE GY HONG

Anticancer Research October 2022, 42 (10) 4937-4943; DOI: https://doi.org/10.21873/anticanres.16000
You have access
Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
You have access
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA

Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
You have access
Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian Cancer
SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

Anticancer Research July 2022, 42 (7) 3707-3716; DOI: https://doi.org/10.21873/anticanres.15860
You have access
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer
SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

Anticancer Research May 2022, 42 (5) 2637-2644; DOI: https://doi.org/10.21873/anticanres.15741
Open Access
Biological Differences Between Ovarian Cancer-associated Fibroblasts and Contralateral Normal Ovary-derived Mesenchymal Stem Cells
KAZUAKI OHASHI, TAO-SHENG LI, SHOKO MIURA, YURI HASEGAWA and KIYONORI MIURA

Anticancer Research April 2022, 42 (4) 1729-1737; DOI: https://doi.org/10.21873/anticanres.15649
You have access
Lactate Is a Reliable Predictor of ICU Length of Stay Following Ultra-radical Ovarian Cancer Surgery
SUSAN ADDLEY, MARK MCGOWAN, VIREN ASHER, ANISH BALI, SUMMI ABDUL, VICTORIA CULLIMORE, HARRIET CROSSLAND and ANDREW PHILLIPS

Anticancer Research April 2022, 42 (4) 1979-1986; DOI: https://doi.org/10.21873/anticanres.15676
You have access
Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy
NAOKI SHIBATA, KAZUYOSHI KAWAKAMI, SHIMIZU HISANORI, KAZUO KOBAYASHI, MAYU YUNOKAWA, HIROYUKI KANAO, IORI TAKI, REMI MURASE, DAISUKE KAMEI and MASAKAZU YAMAGUCHI

Anticancer Research February 2022, 42 (2) 1091-1097; DOI: https://doi.org/10.21873/anticanres.15571
You have access
Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study
ANGIOLO GADDUCCI, ENRICO SIMONETTI, FRANCESCO MEZZAPESA, STEFANIA COSIO, MARIO MICCOLI, JESSICA FREY, RACHELE TINTORI, ALESSANDRA BULLERI and EMANUELE NERI

Anticancer Research February 2022, 42 (2) 947-954; DOI: https://doi.org/10.21873/anticanres.15554

Main menu

User menu

Search

Ovarian cancer

Pages